Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00535769 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use
A Early Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 70
- Enrollment target
NCT00535769: Completed Early Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00535769 is a Early Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00535769, a Early Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if using an electronic reminder improves adherence to sunscreen use. The specific study aims are as follows: 1. To determine whether the use of electronic reminder system increases adherence to topical agents. 2. To assess technological feasibility of measuring adherence to topical agents using electronic monitors specially designed for tubes. 3. To assess technological feasibility of providing electronic reminders using cellular phone text-messaging system. 4. To obtain subjects' feedback on the adherence monitoring and reminder system.
Interventions
- DEVICE Electronic + no text message
- DEVICE Electronic monitor + text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00535769
The ClinicalTrials.gov registry entry for NCT00535769 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electronic + no text message is the first listed.
NCT00535769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00535769 about?
NCT00535769 is a clinical study titled "Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use". The purpose of this study is to determine if using an electronic reminder improves adherence to sunscreen use. The specific study aims are as follows: 1. To determine whether the use of electronic reminder system increases adherence to topical agents. 2. To assess technological feasibility of measu...
What is the current status of trial NCT00535769?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 70 participants. The study started on 2007-09. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00535769?
The interventions under investigation include: Electronic + no text message (DEVICE), Electronic monitor + text messages (DEVICE).
Who is sponsoring clinical trial NCT00535769?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.